Spots Global Cancer Trial Database for Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia
Official Title: Pivotal Study to Validate the Usability, Safety and Diagnostic Performance of a Novel System to Non-Invasively Detect Severe Neutropenia
Study ID: NCT06323447
Interventions
Study Description
Brief Summary: Pivotal study to validate the diagnostic performance of PointCheck, the first non invasive device to preliminary detect neutropenia in cancer patients receiving intermediate/high risk antineoplastic therapy.
Detailed Description:
Keywords
Eligibility
Minimum Age: 10 Years
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Carlos Castro Gonzalez, PhD
Affiliation: Leuko Labs
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
